Skip to main content Skip to section navigation Skip to footer
Aethlon Medical, Inc. Corporate Home
  • The Hemopurifier®
    • Overview
    • The Hemopurifier® in Cancer
    • The Hemopurifier® in Infectious Disease
  • About
    • Overview
    • Leadership
    • Board of Directors
  • News & Media
    • Press Releases
    • Presentations
    • Events
    • Publications
    • Training Videos
  • Investors
    • Overview
    • Corporate News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
    • Analyst Coverage
  • Contact Us
Site Announcement

Aethlon Medical is closely monitoring the Bird Flu situation and stands ready to work alongside hospitals, health agencies and the FDA if existing therapies prove inadequate.

News & Media
  • Press Releases
  • Presentations
  • Events
  • Publications
  • Training Videos

Press Releases

Nov 29, 2017

Aethlon Medical Names Dr. Charles J. Fisher Chairman of the Board

Nov 9, 2017

Dr. Charles J. Fisher, Jr. Joins Aethlon Medical's Board of Directors

Nov 2, 2017

Aethlon Medical Announces Fiscal 2018 Second Quarter Results

Oct 30, 2017

Aethlon Medical to Release Financial Results for the Second Quarter Fiscal Year 2018 and Host Conference Call on November 2, 2017

Oct 16, 2017

Aethlon Medical Announces Large-Scale Production Collaboration

Oct 11, 2017

Aethlon Medical to Present at the 2017 BIO Investor Forum

Oct 10, 2017

Aethlon Medical Announces Compliance With Nasdaq Listing Criteria

Oct 2, 2017

Aethlon Medical Announces Pricing of $6 Million Public Offering

Sep 14, 2017

Aethlon Medical Receives National Cancer Institute Contract Award

Sep 12, 2017

Aethlon Medical Receives Expedited Access Pathway Designation from FDA to Accelerate U.S. Access to the Hemopurifier® as a Treatment for Life-Threatening Viruses

  • Page 1
  • Page 2
  • Page 3
  • Next Pagearrow_forward
rss_feed News RSS
Linkedin
Privacy Policy Disclaimer Sitemap Accessibility Statement
©2025 Aethlon Medical, Inc. All Rights Reserved.